🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in South Korea / NCT07146178
Starting soon Not applicable

Long-term Follow-up of Bio-signals and Quality of Recovery Following Implementation of ERAS

NCT07146178 · tracked via the Priya Life Science South Korea tracker
Phase
Not applicable
Started
2025-09-01
Last updated
2025-08-28

Condition(s) studied

Gynecologic SurgeryGeneral Anesthesia

Investigational drug(s) / intervention(s)

Enhanced Recovery After SurgeryUsual Care

Enhanced Recovery After Surgery: 1. Before surgery * Sips of water until 6 AM on the day of surgery, followed by a 200 mL carbohydrate drink * Pre-emptive oral analgesics (celecoxib 200mg 1 cap + acetaminophen 650mg 2 tab) 2. During surgery * Total intravenous anesthesia * Local anesthetic infiltration at the laparoscopic port site for post-operative pain control 3. After surgery * Sips of water and a foley catheter removal on ward arrival * Soft meal 4 housr after surgery * General diet 8 hours after surgery

Usual Care: 1. Before surgery * Midnight NPO * No pre-emptive analgesics 2. During surgery * Balanced anesthesia 3. After surgery * Sips of water 8 hours after arrival in the ward * Foley catheter removal one day after the surgery * Soft meal after gas out * General diet after one soft meal

Study summary

The goal of this clinical trial is to evaluate the effect of an Enhanced Recovery After Surgery(ERAS) protocol in patients undergoing gynecologic laparoscopic surgery under general anesthesia. The main question it aims to answer is: Does the ERAS protocol improve the quality of recovery compared to standard treatments?

Researchers will compare ERAS protocol with standard treatment to see if ERAS protocol improves the quality of recovery after surgery.

Participants will:

* Receive ERAS protocol during the hospitalization
* Undergo bio-signal monitoring for one month using Hi-Cardi Plus device and Galaxy Watch 7
* Visit the hospital at one week and one month after discharge
* Complete questionnaires(QOR-15K, WHO-DAS 2.0, EQ-5D-3L) at 24 hours after surgery, at discharge, one week after discharge, and one month after discharge

Eligibility

Sex
FEMALE
Min age
20 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Age between 20 and 70 years * Scheduled to undergo gynecologic laparoscopic surgery under general anesthesia * Use of an Android smartphone Exclusion Criteria: * American Society of Anesthesiologists(ASA) physical status classification IV or higher * Body Mass Index (BMI) 35 or higher * Presence of diabetic autonomic neuropathy * History of esophageal hiatal hernia or delayed stomach discharge * Known allergy to local anesthesia * Participantion in other trials that may affect study outcomes * Inability to complete questionnaires (e.g., due to cognitive impairment)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Wonju Severance Christian Hospital Wŏnju Gangwon-do

More Wonju Severance Christian Hospital trials in South Korea

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07146178 on ClinicalTrials.gov ↗ ← All trials in South Korea